Impact of low-level pretransplant donor-specific antibodies detected by the Luminex platform on acute rejection and long-term graft survival
Patients with pretransplant low-level DSAs on Luminex without CDC and FCXM reactivity had good allograft outcomes at 1 year and 10 years as long as they are induced with biological agents and given potent maintenance immunosuppressants.
Authors
- Muhammed Mubarak (ORCID: https://orcid.org/0000-0001-6120-5884)
- Abdul Hafeez (ORCID: https://orcid.org/0000-0002-0272-5190)
- Wajiha Musharraf
- Tahir Aziz (ORCID: https://orcid.org/0000-0002-8878-5062)
- Khawar Abbas
- Mirza Naqi Zafar (ORCID: https://orcid.org/0000-0003-3482-7543)
Institutions
- Sindh Institute of Urology and Transplantation (PK)
Publication Details
- Journal
- World Journal of Transplantation
- Published
- 2025-04-18
- DOI
- https://doi.org/10.5500/wjt.v15.i3.104308
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00